Header image
![](/sites/default/files/styles/page_header_image/public/2023-07/foto_zahlavi_research_1.jpg?itok=p7pBtlZR)
Impact Factor Journals
Novel effective small-molecule inhibitors of protein kinases related to tau pathology in Alzheimer's disease.
Future Medicinal Chemistry.
2022,
14(16),
1175-1186,
ISSN: 1756-8919,
PMID: 35920260,
Missense mutation in RPS7 causes Diamond-Blackfan anemia via alteration of erythrocyte metabolism, protein translation and induction of ribosomal stress.
Blood Cells, Molecules & Diseases.
2022,
97,
102690,
ISSN: 1079-9796,
PMID: 35871033,
Toll-Like Receptor 3 Overexpression Induces Invasion of Prostate Cancer Cells, whereas Its Activation Triggers Apoptosis.
American Journal of Pathology.
2022,
192(9),
1321-1335,
ISSN: 0002-9440,
PMID: 35750257,
3,5,7-Substituted Pyrazolo[4,3- d]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders.
Journal of Medicinal Chemistry.
2022,
65(13),
8881-8896,
ISSN: 0022-2623,
PMID: 35749742,
Drug-like Inhibitors of DC-SIGN Based on a Quinolone Scaffold.
ACS Medicinal Chemistry Letters.
2022,
13(6),
935-942,
ISSN: 1948-5875,
PMID: 35707152,
HLA class II variants defined by next generation sequencing are associated with sarcoidosis in Korean patients.
Scientific Reports.
2022,
12(1),
9302,
ISSN: 2045-2322,
PMID: 35661780,